Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis
Launched by UNIVERSITY OF JENA · Dec 15, 2005
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject has a confirmed diagnosis of cystic fibrosis
- Exclusion Criteria:
- • current systemic therapy against Pseudomonas aeruginosa
About University Of Jena
The University of Jena, a prominent research institution located in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university engages in a wide range of studies aimed at improving patient outcomes and enhancing healthcare practices. Its commitment to ethical standards and rigorous scientific methodology ensures that trials conducted under its auspices contribute valuable insights to the medical community. Through partnerships with various healthcare providers and industry stakeholders, the University of Jena strives to translate research findings into practical applications that benefit society at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jena, Thüringen, Germany
Patients applied
Trial Officials
Jochen G. Mainz, M.D.
Study Chair
University of Jena
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials